🔓 Unlock the full profile of Nirmal Atmaram Bhatia (Veeda Clinical Research Limited), including verified contact details, financial insights, and professional associations.
See Nirmal Atmaram Bhatia Full Profile
From IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: nir*****@vee******.com
Mobile: 83015*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Mr. Nirmal Bhatia serves as the Chief Finance Officer at Veeda Lifesciences, bringing 27 years of extensive experience in finance, legal, taxation, and mergers and acquisitions (M&A).
- He is a Chartered Accountant, underscoring his strong educational and professional background in finance and compliance.
- Nirmal Atmaram Bhatia currently holds multiple roles including Company Secretary at Veeda Clinical Research Limited, reflecting his versatility and leadership across the organization.
- As the Director of Finance/CFO at Veeda Clinical Research Ltd., he has been instrumental in managing financial strategies and operations to support the company’s growth.
- Since June 2021, Nirmal Bhatia has been associated with Veeda Clinical Research Limited, where he oversees legal and financial aspects of the business.
- His leadership encompasses a blend of roles which enhances synergy between financial management and legal compliance within the organization.
- Nirmal's contributions are pivotal in navigating challenges related to finance, legal regulations, and strategic partnership development within the clinical research sector.
- Under his guidance, the finance and legal teams have been able to align their objectives with the company's strategic initiatives, paving the way for operational efficiency.
| CIN/LLP | Company Name | Designation | Appointment Date |
|---|---|---|---|
| U01409KA2007PTC042282 | Bioneeds India Private Limited | Director | 22 Mar 2021 |
| U74999GJ2021PTC120292 | Ingenuity Biosciences Private Limited | Director | 16 Feb 2021 |
| CIN/LLP | Company Name | Designation | Appointment Date | End Date |
|---|